Probiotics for treatment of Clostridium difficile-associated colitis in adults (Q24242821)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Probiotics for treatment of Clostridium difficile-associated colitis in adults (English)

0 references

main subject

probiotics

0 references

Clostridium difficile

0 references

1 reference

Anjana Pillai

1

0 references

Richard L Nelson

series ordinal

2

0 references

language of work or name

English

0 references

publication date

23 January 2008

0 references

published in

0 references

page(s)

CD004611

0 references

issue

1

0 references

cites work

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Behaviour of Saccharomyces boulardii in recurrent Clostridium difficile disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Diagnosis and treatment of Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

How should we respond to the highly toxogenic NAP1/ribotype 027 strain of Clostridium difficile?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

An epidemic, toxin gene-variant strain of Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Quebec to report on Clostridium difficile in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Severe Clostridium difficile colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

The effect of probiotics on Clostridium difficile diarrhea

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Recurrent Clostridium difficile disease: epidemiology and clinical characteristics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Clinical and laboratory observations in Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Probiotics: "living drugs".

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Clostridium difficile: clinical considerations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Probiotics for recurrent Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004611.PUB2

7 January 2021

10.1002/14651858.CD004611.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_bza3x2oexzbbvdk2ancevg7zy4

4931512

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bza3x2oexzbbvdk2ancevg7zy4

24 November 2022

mapped directly with Wikidata item

4931512

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference